In fact, modulation of enzymes involved in sphingolipid metabolism, such as acid and neutral ceramidases has been studied as a therapeutic option in Alzheimer’s disease45,46, cancer research47,48, and diabetes41,46. Here, ASAH2 is linked to cancer.